Quick Answer
Stemtech Corp reported Earnings Per Share Diluted of $0.03 (loss) per share for the year ending 2024.
- Stemtech Corp showed an increase of +57.1% in Earnings Per Share Diluted from 2023 to 2024.
- This data is from Stemtech Corp's annual report (Form 10-K), filed with the SEC on June 30, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $0.02 per share | Q1 2021: $0.00 per share | Q2 2021: $0.02 (loss) per share | Q3 2021: $0.28 (loss) per share | Q1 2022: $0.01 (loss) per share | Q2 2022: $0.56 (loss) per share | Q3 2022: $0.38 per share | Q1 2023: $0.04 (loss) per share | Q2 2023: $0.00 per share | Q3 2023: $0.01 (loss) per share | Q1 2024: $0.02 (loss) per share | Q2 2024: $0.01 (loss) per share | Q3 2024: $0.01 (loss) per share | Q1 2025: $0.01 (loss) per share | Q2 2025: $0.00 per share | Q3 2025: $0.01 (loss) per share.
- Over the full 5 years of available data (2020 to 2024), Stemtech Corp's Earnings Per Share Diluted has grown by 70.0%.
- Historical annual values: Fiscal year 2024: $0.03 (loss) per share | Fiscal year 2023: $0.07 (loss) per share | Fiscal year 2022: $0.19 (loss) per share | Fiscal year 2021: $0.20 (loss) per share | Fiscal year 2020: $0.10 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: